摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-(tert-butylcarbamoyloxy)ethoxy]-4,6-dimethylisothiazolo[5,4-b]pyridine | 1449783-83-8

中文名称
——
中文别名
——
英文名称
3-[2-(tert-butylcarbamoyloxy)ethoxy]-4,6-dimethylisothiazolo[5,4-b]pyridine
英文别名
2-[(4,6-dimethyl-[1,2]thiazolo[5,4-b]pyridin-3-yl)oxy]ethyl N-tert-butylcarbamate
3-[2-(tert-butylcarbamoyloxy)ethoxy]-4,6-dimethylisothiazolo[5,4-b]pyridine化学式
CAS
1449783-83-8
化学式
C15H21N3O3S
mdl
——
分子量
323.416
InChiKey
MCKKDXDOWDFXSO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    102
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-[(4,6-Dimethyl-[1,2]thiazolo[5,4-b]pyridin-3-yl)oxy]ethanol叔丁基异氰酸酯三乙烯二胺 作用下, 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂, 反应 5.0h, 以30.5%的产率得到3-[2-(tert-butylcarbamoyloxy)ethoxy]-4,6-dimethylisothiazolo[5,4-b]pyridine
    参考文献:
    名称:
    Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes
    摘要:
    In this paper we describe synthesis, structures and some physicochemical properties of 20 isothiazolopyridines 8-13 substituted differently into an isothiazole ring as well as their in vitro antibacterial assays against Mycobacterium tuberculosis H37Rv, Mycobacterium fortuitum PCM 672 and Propionibacterium acnes PCM 2400. Compound 13a was found to be the most active derivative against M. tuberculosis H37Rv, demonstrating 100% growth inhibition of microorganisms in the primary screen (minimum inhibitory concentration [MIC] 6.25 mu g/mL). Nineteen of the prepared compounds were evaluated against M. fortuitum PCM 672 and P. acnes PCM 2400 and only compounds 9 and 12d exhibited excellent activity against individual strains of microorganisms with MIC90 <1 mu g/mL. The inhibitory action of the remaining isothiazolopyridines towards the tested strains of the microorganism was low, absent, or a non-linear correlation prohibited accurate determination of MIC values. Unexpectedly, seven of the remaining isothiazolopyridines tested against M. fortuitum and P. acnes stimulated growth of the microorganisms in the range 10-50% or even more (10b) under experimental conditions. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.06.027
点击查看最新优质反应信息

文献信息

  • Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes
    作者:Wiesław Malinka、Piotr Świątek、Małgorzata Śliwińska、Bogumiła Szponar、Andrzej Gamian、Zbigniew Karczmarzyk、Andrzej Fruziński
    DOI:10.1016/j.bmc.2013.06.027
    日期:2013.9
    In this paper we describe synthesis, structures and some physicochemical properties of 20 isothiazolopyridines 8-13 substituted differently into an isothiazole ring as well as their in vitro antibacterial assays against Mycobacterium tuberculosis H37Rv, Mycobacterium fortuitum PCM 672 and Propionibacterium acnes PCM 2400. Compound 13a was found to be the most active derivative against M. tuberculosis H37Rv, demonstrating 100% growth inhibition of microorganisms in the primary screen (minimum inhibitory concentration [MIC] 6.25 mu g/mL). Nineteen of the prepared compounds were evaluated against M. fortuitum PCM 672 and P. acnes PCM 2400 and only compounds 9 and 12d exhibited excellent activity against individual strains of microorganisms with MIC90 <1 mu g/mL. The inhibitory action of the remaining isothiazolopyridines towards the tested strains of the microorganism was low, absent, or a non-linear correlation prohibited accurate determination of MIC values. Unexpectedly, seven of the remaining isothiazolopyridines tested against M. fortuitum and P. acnes stimulated growth of the microorganisms in the range 10-50% or even more (10b) under experimental conditions. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
查看更多